News - Highlighted News

New treatment in flu vaccine controversy

Written by Robert Hodgson      
Tuesday, 20 October 2009

A 64-year-old woman died last week just two days after receiving an inoculation against the new A(H1N1) influenza virus dubbed swine flu. The state medical service ÁNTSZ ordered an autopsy to establish whether there was any link between the vaccine and the death of the patient, who suffered from chronic, but mild, heart disease.

New fatality

Last week also saw Hungary’s fourth fatality attributed to A(H1N1) infection. A 47-year-old man who died in hospital was found to have been infected with the virus, health minister Tamás Székely told reporters last Thursday. The patient was being treated for pneumonia.

Hungary’s chief medical officer Ferenc Falus addressed a parliamentary Health Committee last Wednesday and urged Hungarians to get themselves vaccinated as quickly as possible. Falus had himself inoculated in front of reporters in a bid to quell public fears over the safety of the vaccine. The previous week, the manufacturer of Hungary’s A(H1N1) vaccine, Omninvest, had threatened to sue media for “scaremongering” by suggesting the vaccine could be ineffective or dangerous.

Winter epidemic possible

Meanwhile, the ÁNTSZ warned that infection could reach epidemic proportions by early next year following the onset of winter weather. Fewer than 300 cases of A(H1N1) infection have been confirmed in Hungary since the virus was first detected in humans. However, the week before last, some 16,000 cases of influenza were registered nationwide, and it is likely that a good deal, if not most, of these are down to the new variant virus.

Hungary's new flu vaccine not suitable for children, pregnant women, says health advisor

The vaccine against the new flu virus is not suitable for small children and pregnant women, a member of Hungary's Collegium for Infectology, an advisor to the Health Ministry, said in a television programme on TV2 on Sunday evening.

Pregnant women should instead be treated with antiviral products, of which there is not enough in the country, Andras Szalka said.

The Health Ministry responded that it had not to date received a statement from the Collegium to this effect, however, it added that Chief Medical Officer Ferenc Falus has called a meeting of the pandemic committee for Monday, where this matter would be discussed.

The fourth patient died in Hungary on Thursday associated with the new flu A/H1N1 virus. The virus had been revealed in 283 cases since it appeared in Hungary in May

Original article

---

Add this page to Social Bookmarking websites

---

Thank you for helping spreading the news!

Comments

Add New Search RSS

LIES WHEN YOU DIE FROM VAX UK 2009-11-01 09:53:51 How can anyone be sure they dont have an underlying health problem.? Because everyone whos died theyve said they had underlying problems they have an excuse for everyone. ANYONE Person could have an underlying problem get the vaccination and drop dead IS IT WISE TO GIVE TO KNOWN CASES OF UNDERLYING PROBLEMS???? IS IT WISE TO GET THIS TOXIC SHOCK VACCINATION AT ALL????????? I DONT THINK ITS WISE AT ALL. It could be YOU It could be ME And Im not going to be forced into taking that chance. This vaccination should be stopped NOW Its killing people who could have had more years left with thier families and just because theyve took this fucking murdering vax they are NOW DEAD ReplyQuote 0 0

Norway receives 170.000 vaccine doses less than or Nikolaj 2009-11-01 14:00:00 ..or is it just because "not enough" people want to take the dangerous flu shot in Norway? http://www.fhi.no/eway/default.aspx?pid=233&trg=MainLeft_5565&MainArea _5661=5565:0:15,5034:1:0:0:::0:0&MainLeft_5565=5544:80911::1:5569:2::: 0:0 ReplyQuote 0 0

UNITED KINGDOM (( URGENT )) Doctors plan MASS swine flu ja 2009-11-01 22:58:36 Doctors plan mass swine flu jabs for under-18s Steven Swinford (( Times Online)) Government advisers are preparing for the mass vaccination of schoolchildren to stop the spread of swine flu. A committee of scientists advising the Department of Health is expected to recommend that the vaccination of 10 to 18-year-olds begins by the end of the year. The plans come amid growing concern about the number and severity of infections in children. Figures released last week show that children under the age of 15 account for a fifth of all swine flu hospital admissions. A total of 217 children have been treated in hospital, including 27 who are in critical care. Overall, the number of new cases in England increased by 50% last week to 78,000. The government’s vaccination programme, which began last month, is targeting 11m priority patients and frontline health workers. The patients include pregnant women and those with conditions such as asthma and diabetes. Last month the joint committee on vaccination and immunisation discussed extending the programme to include under-18s, once the priority cases have been vaccinated. If the virus continues to spread at current rates and enough vaccine is available, it will be extended to schoolchildren. Professor Peter Openshaw, an expert on respiratory infections at Imperial College London and a member of the committee, said: “As increasing quantities of vaccine become available, then the initial recommendations will be extended [to children and teenagers]. “It depends on the emerging circumstances such as the efficacy and availability of the vaccine and the spread of the virus.” Scientists believe the virus is more severe in children because they have not been exposed to related outbreaks. The elderly, by contrast, have not suffered as badly. The United States is already offering immunisation to everyone aged from six months to 24 years, in addition to at-risk groups. In Britain, vaccination is likely to focus initially on children aged 10 to 18. The committee is waiting for further research to be completed about the effectiveness of the vaccine in younger children. The move to vaccinate children was backed by the Royal College of General Practitioners. Steve Field, its chairman, said: “If there is enough vaccine available, it would be sensible to use it for children, who are the most vulnerable. They have had no previous immunisation or exposure to the virus.” A spokesman for the Department of Health said: “The vaccination programme is in its early stages, allowing time to plan for which groups will be offered the vaccine next. A decision has not yet been made.” THE LINK TO Times Online http://www.timesonline.co.uk/tol/news/uk/health/Swine_flu/article68981 87.ece ReplyQuote 0 0

GSK admits to serious side effects in the package Harish 2009-11-02 10:16:21 GSK admits to serious side effects in the package insert for AREPANRIX™ H1N1/AS03-Adjuvanted H1N1 Pandemic Influenza Vaccine. Note: This is written in plain english as opposed to the adverse effects as seen in the clinical trials. See Page 8 of the insert for adverse reactions in clinical studies to the AREPANRIX™ H1N1/AS03-Adjuvanted H1N1 vaccine. SIDE EFFECTS AND WHAT TO DO ABOUT THEM As with all medicines, AREPANRIX™ H1N1 can cause side effects. The very common and common side effects are usually mild and should only last a day or two. Very common (may occur with more than 1 in 10 doses): • Pain at the injection site • Headache • Fatigue • Redness or swelling at the injection site • Shivering • Sweating • Aching muscles, joint pain Common (may occur with up to 1 in 10 doses): • Reactions at the injection site such as bruising, itching and warmth • Fever • Swollen lympth nodes • Feeling sick, diarrhea Uncommon (may occur with up to 1 in 100 doses): • Dizziness • Generally feeling unwell • Unusual weakness • Vomiting, stomach pain, uncomfortable feeling in the stomach or belching after eating • Inability to sleep • Tingling or numbness of the hands or feet • Shortness of breath • Pain in the chest • Itching, rash • Pain in the back or neck, stiffness in the muscles, muscle spasms, pain in extremity such as leg or hand Rare (may occur with up to 1 in 1000 doses): • Allergic reactions leading to a dangerous decrease of blood pressure, which, if untreated, may lead to shock. Doctors are aware of this possibility and have emergency treatment available for use in such cases • Fits • Severe stabbing or throbbing pain along one or more nerves • Low blood platelet count which can result in bleeding or bruising Very Rare (may occur with up to 1 in 10,000 doses): • Vasculitis (inflammation of the blood vessels which can cause skin rashes, joint pain and kidney problems) • Neurological disorders such as encephalomyelitis (inflammation of the central nervous system), neuritis (inflammation of nerves) and a type of paralysis known a Guillain-Barré Syndrome If any of these side effects occur, please tell your doctor or nurse immediately. If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor. Serious Warnings and Precautions Advise your doctor or nurse immediately if you experience these reactions shortly after receiving your injection: • body rash • tightness in the throat • shortness of breath http://preventdisease.com/news/pdf/GSK_Arepanrix_October_2009.pdf ReplyQuote 0 0

Write comment
Name:
Email:	do not notifynotify
Website:
Title:
UBBCode:	-color-aquablackbluefuchsiagraygreenlimemaroonnavyolivepurpleredsilvertealwhiteyellow -size-tinysmallmediumlargehuge
Please input the anti-spam code that you can read in the image.